Global Bioactive Wound Management Market to Reach US$2.5 Billion by the Year 2026

New York, Jan. 19, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Bioactive Wound Management Industry" - https://www.reportlinker.com/p06044437/?utm_source=GNW
They contain bioactive substances that remain active during the process of wound healing. The global bioactive wound management market is growing led by factors including an ageing population, growing prevalence of tissue disorders, and escalating cases of chronic wounds. The growing prevalence of lifestyle associated disorders, especially diabetes is giving rise to diabetic foot ulcers, pressure ulcers, and venous leg ulcers. The number of people (adults aged between 20-79 years) with diabetes is expected to grow from about 463 million in 2019 to reach 700 million by 2045. These numbers also indicate the ratio of those suffering from Type II diabetes to increase in most countries. Overall, these growing cases represent opportunities and undeterred growth for global bioactive wound care management market in the coming years. At the same time, skin injuries and wound infection are also key factors driving demand for bioactive wound care management. Meanwhile, wound infection is one of the key concerns for both healthcare providers and patients across the world, and the need for effective care and management for lowering infection makes way for bioactive wound care management solutions. The market already offers technologically advanced products such as occlusive dressings for skin injuries that allow a moist environment to be maintained for promoting active healing, and keratin-based products that when used together with injury dressings allow re-epithelialization of damaged skin tissue.

Amid the COVID-19 crisis, the global market for Bioactive Wound Management estimated at US$1.6 Billion in the year 2020, is projected to reach a revised size of US$2.5 Billion by 2026, growing at a CAGR of 7.8% over the analysis period. Alginates, one of the segments analyzed in the report, is projected to grow at a 6.8% CAGR to reach US$826.1 Million by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Collagen-Based Dressings segment is readjusted to a revised 9.1% CAGR for the next 7-year period. This segment currently accounts for a 23.9% share of the global Bioactive Wound Management market. Alginate dressing is made using highly absorbent materials to promote wound healing. This dressing finds use in exudant wounds where excess fluid is present. A key trend in the advanced wound care market is the emergence of combination dressings which are prepared using various available products of wound dressings in several different combinations, most generally including a biological agent and an antimicrobial material. Collagen and foam dressings, collagen hydrocolloid dressings, silver collagen dressings, and silver alginate dressings are some of the combination dressings that are being used for the treatment of chronic wounds.

The U.S. Market is Estimated at $650.9 Million in 2021, While China is Forecast to Reach $211.3 Million by 2026

The Bioactive Wound Management market in the U.S. is estimated at US$650.9 Million in the year 2021. The country currently accounts for a 38.66% share in the global market. China, the world`s second largest economy, is forecast to reach an estimated market size of US$211.3 Million in the year 2026 trailing a CAGR of 9.8% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.4% and 6.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.5% CAGR while Rest of European market (as defined in the study) will reach US$220.8 Million by the end of the analysis period. North America has emerged as a leading global market for advanced wound care management technologies such as bioactive wound care dressings. The regional market benefits from a rapidly expanding base of ageing population, a sizeable diabetic population, and higher prevalence of chronic diseases. The Asia-Pacific market for bioactive wound management is fast growing owing to an expanding diabetic population, with increased incidence of infections, pressure ulcers and diabetic foot among others.

Antimicrobial Dressings Segment to Reach $434 Million by 2026

Antimicrobial dressings are wound dressings that include an antiseptic agent that helps destroy microorganisms present in the wound. These dressings are mainly used for wounds that fail to heal due to increasing bacterial load, and for wounds that have a high risk of infection. Rise in demand for these dressings is also due to the growing need to reduce hospital acquired infections, and rising prevalence of bacteria which is resistant to antibiotics. In the global Antimicrobial Dressings segment, USA, Canada, Japan, China and Europe will drive the 6.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$248.1 Million in the year 2020 will reach a projected size of US$377.5 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$27.8 Million by the year 2026.


Select Competitors (Total 90 Featured)

• 3M Company
• Acelity LP, Inc.
• ACell Inc.
• Convatec Group PLC
• Covalon Technologies Ltd.
• Integra LifeSciences Holdings Corporation
• MiMedx Group, Inc.
• Smith & Nephew PLC
• SYMATESE
• Wright Medical Group NV

Read the full report: https://www.reportlinker.com/p06044437/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Impact of Covid-19 and a Looming Global Recession
2020: A Year of Disruption & Transformation
As the Race between the Virus & Vaccines Intensifies, Review of
the World Economy in 2021
EXHIBIT 1: World Economic Growth Projections (Real GDP, Annual
% Change) for 2020 through 2022
COVID-19-Led Wound Management Crisis & Patient Suffering Create
Need for Effective Interventions
Dwindling Revenues for Wound Care Practices
Telemedicine, Remote Patient Monitoring Takes Center Stage
Wounds & Wound Management: An Insight
Bioactive Wound Management: A Prelude
Outlook
Healthcare Burden of Chronic Wounds and the Need for Effective
Wound Management Products
Prevalence and Incidence of Wounds - Select Statistics
EXHIBIT 2: Global Prevalence of Wounds by Type (in Millions)
EXHIBIT 3: Global Wound Care Market: Percentage Breakdown of
Spending by Wound Type
EXHIBIT 4: Healing Time by Type of Wound (in Days)
Chronic Wounds: Select Statistics
Reduced Economic Cost of Wound Care Triggers Transition to
Advanced Products
EXHIBIT 5: Breakdown of Costs Associated with Wound Care
Recent Market Activity

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS
Effective Burn Wound Management with Bioactive Dressings
Uptrend in Surgical Care Augurs Well for Market Growth
EXHIBIT 6: Global Surgical Procedure Volume by Procedure Type
Rise in Prevalence of Pressure Ulcers and the Growing Focus on
Treatment Solutions
EXHIBIT 7: Pressure Ulcer Occurrence Rate Based on the Length
of Surgery
Understanding the Wound: A Widening Area of Interest
Smart? Dressings Set the Road to Futuristic Wound Care
Startups Enter the Fray
Growing Focus on Reducing Hospital Stays Lends Traction
Technological Advancements Remain Buoyant
Conductive Bio-material Wound Dressings Beneficial for Wound
Healing
Combination Dressings Emerge as a Key Trend
Cellulose-based Dressings Exude Immense Potential for Chronic
Wound Management
3D-Printed Stem Cells & Lasers to Kill Bacteria
New Bioactive Wound Dressings
Chitin, Chitosan and Derivatives
Bioactive Glasses Show Promising Wound Healing Outcomes
Rising Incidence of Diabetes and DFUs to Propel Market Growth
EXHIBIT 8: World Diabetes and Population Statistics (2019, 2030 &
2045)
EXHIBIT 9: Global Diabetes Mellitus Population Breakdown by
Geographic Region: 2019, 2030 and 2045
EXHIBIT 10: World Diabetes Prevalence (2000 - 2019)
COVID-19 Crisis & Restrictions Upend Care for Diabetic Foot
Disease Patients
Growing Acceptance of Moist Wound Environment Spurs Demand for
Moist Wound Dressings
Alginate Dressings Dominate the Market
Antimicrobial Dressings Find Application for Healing Wounds
with High Bacterial Load
Multi-Drug Resistant Bacteria: A Pressing Concern
Tissue Engineering in Wound Care
Bioengineered Skin Substitutes
Collagen Dressings in Advanced Wound Care
Macro Growth Drivers
Impact of Healthcare Expenditure on Market Growth
EXHIBIT 11: World Healthcare Expenditure (In US$ Billion) for
the Years 2017-2023
EXHIBIT 12: Elderly Healthcare Expenditure as a % of GDP for
1970, 2010 and 2050
Expanding Aging Population Spurs Demand
EXHIBIT 13: Global Population Statistics for the 65+ Age Group
in Million by Geographic Region for the Years 2019, 2025, 2035
and 2050
Growing Obesity Levels Fuel Demand
EXHIBIT 14: Global Obesity Epidemic: Percentage of Overweight,
Obese, and Severely Obese Adults for 2014 & 2025

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Bioactive Wound
Management by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 2: World Historic Review for Bioactive Wound Management
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2016 through 2019 and
% CAGR

Table 3: World 11-Year Perspective for Bioactive Wound
Management by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets for Years 2016, 2021 & 2027

Table 4: World Current & Future Analysis for Alginates by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 5: World Historic Review for Alginates by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2016 through 2019 and % CAGR

Table 6: World 11-Year Perspective for Alginates by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2016, 2021 & 2027

Table 7: World Current & Future Analysis for Collagen-Based
Dressings by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 8: World Historic Review for Collagen-Based Dressings by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2016 through 2019 and
% CAGR

Table 9: World 11-Year Perspective for Collagen-Based Dressings
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2016, 2021 & 2027

Table 10: World Current & Future Analysis for Antimicrobial
Dressings by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 11: World Historic Review for Antimicrobial Dressings by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2016 through 2019 and
% CAGR

Table 12: World 11-Year Perspective for Antimicrobial Dressings
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2016, 2021 & 2027

Table 13: World Current & Future Analysis for Bioengineered
Skin Substitutes by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 14: World Historic Review for Bioengineered Skin
Substitutes by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2016 through
2019 and % CAGR

Table 15: World 11-Year Perspective for Bioengineered Skin
Substitutes by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World for Years 2016, 2021 & 2027

Table 16: World Current & Future Analysis for Hydrocolloids by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 17: World Historic Review for Hydrocolloids by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2016 through 2019 and % CAGR

Table 18: World 11-Year Perspective for Hydrocolloids by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2016, 2021 & 2027

Table 19: World Current & Future Analysis for Burn Wounds by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 20: World Historic Review for Burn Wounds by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2016 through 2019 and % CAGR

Table 21: World 11-Year Perspective for Burn Wounds by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2016, 2021 & 2027

Table 22: World Current & Future Analysis for Surgical Wounds
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 23: World Historic Review for Surgical Wounds by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2016 through 2019 and
% CAGR

Table 24: World 11-Year Perspective for Surgical Wounds by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2016, 2021 & 2027

Table 25: World Current & Future Analysis for Diabetic Foot
Ulcers by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 26: World Historic Review for Diabetic Foot Ulcers by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2016 through 2019 and
% CAGR

Table 27: World 11-Year Perspective for Diabetic Foot Ulcers by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2016, 2021 & 2027

Table 28: World Current & Future Analysis for Venous Leg Ulcers
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 29: World Historic Review for Venous Leg Ulcers by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2016 through 2019 and
% CAGR

Table 30: World 11-Year Perspective for Venous Leg Ulcers by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2016, 2021 & 2027

Table 31: World Current & Future Analysis for Pressure Ulcers
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 32: World Historic Review for Pressure Ulcers by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2016 through 2019 and
% CAGR

Table 33: World 11-Year Perspective for Pressure Ulcers by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2016, 2021 & 2027

Table 34: World Current & Future Analysis for Hospitals &
Clinics by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 35: World Historic Review for Hospitals & Clinics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2016 through 2019 and
% CAGR

Table 36: World 11-Year Perspective for Hospitals & Clinics by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2016, 2021 & 2027

Table 37: World Current & Future Analysis for Ambulatory
Surgical Centers by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 38: World Historic Review for Ambulatory Surgical Centers
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2016 through 2019 and
% CAGR

Table 39: World 11-Year Perspective for Ambulatory Surgical
Centers by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2016, 2021 & 2027

Table 40: World Current & Future Analysis for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 41: World Historic Review for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2016 through 2019 and
% CAGR

Table 42: World 11-Year Perspective for Other End-Uses by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2016, 2021 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 43: USA Current & Future Analysis for Bioactive Wound
Management by Product - Alginates, Collagen-Based Dressings,
Antimicrobial Dressings, Bioengineered Skin Substitutes and
Hydrocolloids - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 44: USA Historic Review for Bioactive Wound Management by
Product - Alginates, Collagen-Based Dressings, Antimicrobial
Dressings, Bioengineered Skin Substitutes and Hydrocolloids
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2016 through 2019 and % CAGR

Table 45: USA 11-Year Perspective for Bioactive Wound
Management by Product - Percentage Breakdown of Value Sales for
Alginates, Collagen-Based Dressings, Antimicrobial Dressings,
Bioengineered Skin Substitutes and Hydrocolloids for the Years
2016, 2021 & 2027

Table 46: USA Current & Future Analysis for Bioactive Wound
Management by Application - Burn Wounds, Surgical Wounds,
Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 47: USA Historic Review for Bioactive Wound Management by
Application - Burn Wounds, Surgical Wounds, Diabetic Foot
Ulcers, Venous Leg Ulcers and Pressure Ulcers Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2016 through 2019 and % CAGR

Table 48: USA 11-Year Perspective for Bioactive Wound
Management by Application - Percentage Breakdown of Value Sales
for Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous
Leg Ulcers and Pressure Ulcers for the Years 2016, 2021 & 2027

Table 49: USA Current & Future Analysis for Bioactive Wound
Management by End-Use - Hospitals & Clinics, Ambulatory
Surgical Centers and Other End-Uses - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 50: USA Historic Review for Bioactive Wound Management by
End-Use - Hospitals & Clinics, Ambulatory Surgical Centers and
Other End-Uses Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2016 through 2019 and % CAGR

Table 51: USA 11-Year Perspective for Bioactive Wound
Management by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Clinics, Ambulatory Surgical Centers and Other
End-Uses for the Years 2016, 2021 & 2027

CANADA
Table 52: Canada Current & Future Analysis for Bioactive Wound
Management by Product - Alginates, Collagen-Based Dressings,
Antimicrobial Dressings, Bioengineered Skin Substitutes and
Hydrocolloids - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 53: Canada Historic Review for Bioactive Wound Management
by Product - Alginates, Collagen-Based Dressings, Antimicrobial
Dressings, Bioengineered Skin Substitutes and Hydrocolloids
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2016 through 2019 and % CAGR

Table 54: Canada 11-Year Perspective for Bioactive Wound
Management by Product - Percentage Breakdown of Value Sales for
Alginates, Collagen-Based Dressings, Antimicrobial Dressings,
Bioengineered Skin Substitutes and Hydrocolloids for the Years
2016, 2021 & 2027

Table 55: Canada Current & Future Analysis for Bioactive Wound
Management by Application - Burn Wounds, Surgical Wounds,
Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 56: Canada Historic Review for Bioactive Wound Management
by Application - Burn Wounds, Surgical Wounds, Diabetic Foot
Ulcers, Venous Leg Ulcers and Pressure Ulcers Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2016 through 2019 and % CAGR

Table 57: Canada 11-Year Perspective for Bioactive Wound
Management by Application - Percentage Breakdown of Value Sales
for Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous
Leg Ulcers and Pressure Ulcers for the Years 2016, 2021 & 2027

Table 58: Canada Current & Future Analysis for Bioactive Wound
Management by End-Use - Hospitals & Clinics, Ambulatory
Surgical Centers and Other End-Uses - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 59: Canada Historic Review for Bioactive Wound Management
by End-Use - Hospitals & Clinics, Ambulatory Surgical Centers
and Other End-Uses Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2016 through 2019 and % CAGR

Table 60: Canada 11-Year Perspective for Bioactive Wound
Management by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Clinics, Ambulatory Surgical Centers and Other
End-Uses for the Years 2016, 2021 & 2027

JAPAN
Table 61: Japan Current & Future Analysis for Bioactive Wound
Management by Product - Alginates, Collagen-Based Dressings,
Antimicrobial Dressings, Bioengineered Skin Substitutes and
Hydrocolloids - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 62: Japan Historic Review for Bioactive Wound Management
by Product - Alginates, Collagen-Based Dressings, Antimicrobial
Dressings, Bioengineered Skin Substitutes and Hydrocolloids
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2016 through 2019 and % CAGR

Table 63: Japan 11-Year Perspective for Bioactive Wound
Management by Product - Percentage Breakdown of Value Sales for
Alginates, Collagen-Based Dressings, Antimicrobial Dressings,
Bioengineered Skin Substitutes and Hydrocolloids for the Years
2016, 2021 & 2027

Table 64: Japan Current & Future Analysis for Bioactive Wound
Management by Application - Burn Wounds, Surgical Wounds,
Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 65: Japan Historic Review for Bioactive Wound Management
by Application - Burn Wounds, Surgical Wounds, Diabetic Foot
Ulcers, Venous Leg Ulcers and Pressure Ulcers Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2016 through 2019 and % CAGR

Table 66: Japan 11-Year Perspective for Bioactive Wound
Management by Application - Percentage Breakdown of Value Sales
for Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous
Leg Ulcers and Pressure Ulcers for the Years 2016, 2021 & 2027

Table 67: Japan Current & Future Analysis for Bioactive Wound
Management by End-Use - Hospitals & Clinics, Ambulatory
Surgical Centers and Other End-Uses - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 68: Japan Historic Review for Bioactive Wound Management
by End-Use - Hospitals & Clinics, Ambulatory Surgical Centers
and Other End-Uses Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2016 through 2019 and % CAGR

Table 69: Japan 11-Year Perspective for Bioactive Wound
Management by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Clinics, Ambulatory Surgical Centers and Other
End-Uses for the Years 2016, 2021 & 2027

CHINA
Table 70: China Current & Future Analysis for Bioactive Wound
Management by Product - Alginates, Collagen-Based Dressings,
Antimicrobial Dressings, Bioengineered Skin Substitutes and
Hydrocolloids - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 71: China Historic Review for Bioactive Wound Management
by Product - Alginates, Collagen-Based Dressings, Antimicrobial
Dressings, Bioengineered Skin Substitutes and Hydrocolloids
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2016 through 2019 and % CAGR

Table 72: China 11-Year Perspective for Bioactive Wound
Management by Product - Percentage Breakdown of Value Sales for
Alginates, Collagen-Based Dressings, Antimicrobial Dressings,
Bioengineered Skin Substitutes and Hydrocolloids for the Years
2016, 2021 & 2027

Table 73: China Current & Future Analysis for Bioactive Wound
Management by Application - Burn Wounds, Surgical Wounds,
Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 74: China Historic Review for Bioactive Wound Management
by Application - Burn Wounds, Surgical Wounds, Diabetic Foot
Ulcers, Venous Leg Ulcers and Pressure Ulcers Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2016 through 2019 and % CAGR

Table 75: China 11-Year Perspective for Bioactive Wound
Management by Application - Percentage Breakdown of Value Sales
for Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous
Leg Ulcers and Pressure Ulcers for the Years 2016, 2021 & 2027

Table 76: China Current & Future Analysis for Bioactive Wound
Management by End-Use - Hospitals & Clinics, Ambulatory
Surgical Centers and Other End-Uses - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 77: China Historic Review for Bioactive Wound Management
by End-Use - Hospitals & Clinics, Ambulatory Surgical Centers
and Other End-Uses Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2016 through 2019 and % CAGR

Table 78: China 11-Year Perspective for Bioactive Wound
Management by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Clinics, Ambulatory Surgical Centers and Other
End-Uses for the Years 2016, 2021 & 2027

EUROPE
Table 79: Europe Current & Future Analysis for Bioactive Wound
Management by Geographic Region - France, Germany, Italy, UK
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

Table 80: Europe Historic Review for Bioactive Wound Management
by Geographic Region - France, Germany, Italy, UK and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2016 through 2019 and % CAGR

Table 81: Europe 11-Year Perspective for Bioactive Wound
Management by Geographic Region - Percentage Breakdown of Value
Sales for France, Germany, Italy, UK and Rest of Europe Markets
for Years 2016, 2021 & 2027

Table 82: Europe Current & Future Analysis for Bioactive Wound
Management by Product - Alginates, Collagen-Based Dressings,
Antimicrobial Dressings, Bioengineered Skin Substitutes and
Hydrocolloids - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 83: Europe Historic Review for Bioactive Wound Management
by Product - Alginates, Collagen-Based Dressings, Antimicrobial
Dressings, Bioengineered Skin Substitutes and Hydrocolloids
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2016 through 2019 and % CAGR

Table 84: Europe 11-Year Perspective for Bioactive Wound
Management by Product - Percentage Breakdown of Value Sales for
Alginates, Collagen-Based Dressings, Antimicrobial Dressings,
Bioengineered Skin Substitutes and Hydrocolloids for the Years
2016, 2021 & 2027

Table 85: Europe Current & Future Analysis for Bioactive Wound
Management by Application - Burn Wounds, Surgical Wounds,
Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 86: Europe Historic Review for Bioactive Wound Management
by Application - Burn Wounds, Surgical Wounds, Diabetic Foot
Ulcers, Venous Leg Ulcers and Pressure Ulcers Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2016 through 2019 and % CAGR

Table 87: Europe 11-Year Perspective for Bioactive Wound
Management by Application - Percentage Breakdown of Value Sales
for Burn Wounds, Surgical Wounds, Diabetic Foot Ulcers, Venous
Leg Ulcers and Pressure Ulcers for the Years 2016, 2021 & 2027

Table 88: Europe Current & Future Analysis for Bioactive Wound
Management by End-Use - Hospitals & Clinics, Ambulatory
Surgical Centers and Other End-Uses - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 89: Europe Historic Review for Bioactive Wound Management
by End-Use - Hospitals & Clinics, Ambulatory Surgical Centers
and Other End-Uses Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2016 through 2019 and % CAGR

Table 90: Europe 11-Year Perspective for Bioactive Wound
Management by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Clinics, Ambulatory Surgical Centers and Other
End-Uses for the Years 2016, 2021 & 2027

FRANCE
Table 91: France Current & Future Analysis for Bioactive Wound
Management by Product - Alginates, Collagen-Based Dressings,
Antimicrobial Dressings, Bioengineered Skin Substitutes and
Hydrocolloids - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 92: France Historic Review for Bioactive Wound Management
by Product - Alginates, Collagen-Based Dressings, Antimicrobial
Dressings, Bioengineered Skin Substitutes and Hydrocolloids
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2016 through 2019 and % CAGR

Table 93: France 11-Year Perspective for Bioactive Wound
Management by Product - Percentage Breakdown of Value Sales for
Alginates, Collagen-Based Dressings, Antimicrobial Dressings,
Bioengineered Skin Substitutes and Hydrocolloids for the Years
2016, 2021 & 2027

Table 94: France Current & Future Analysis for Bioactive Wound
Management by Application - Burn Wounds, Surgical Wounds,
Diabetic Foot Ulcers, Venous Leg Ulcers and Pressure Ulcers -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 95: France Historic Review for Bioactive Wound Management
by Application - Burn Wounds, Surgical Wounds, Diabetic Foot
Ulcers, Venous Leg Ulcers and Pressure Ulcers Markets -

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06044437/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001